Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Fortini

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Revue Medicale Suisse|July 17, 2012
[Learning motivational interviewing to help patients change their health-related behaviors: medical students confirm it]C Fortini, J-B Daeppen
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics|September 1, 1982
[Problems of the therapy of neonatal convulsions]P Scarpa, R Chierici, C Fortini
Helvetica Paediatrica Acta|December 1, 1986
Neonatal periventricular leukomalacia: diagnosis and evolution evaluated by real-time ultrasoundL Tamisari, V Vigi, C Fortini, et al.
Brain & Development|January 1, 1983
Criteria for discontinuing neonatal seizure therapy: a long-term appraisalP Scarpa, R Chierici, L Tamisari, et al.
Revue Medicale Suisse|October 27, 2006
[Motivational interviewing: some theoretical aspects and some practical exercises]P Gache, C Fortini, A Meynard, et al.
Scandinavian Journal of Immunology|November 13, 2008
Inhibition of serine-peptidase activity enhances the generation of a survivin-derived HLA-A2-presented CTL epitope in colon-carcinoma cellsG Preta, D Marescotti, C Fortini, et al.
Human Genetics|September 1, 1993
Molecular analysis of G6PD variants in northern Italy: a study on the population from the Ferrara districtP Ninfali, L Baronciani, A Ruzzo, et al.
Annals of the New York Academy of Sciences|June 12, 2010
Immunological modifications during treatment with thymosin alpha1 plus antiviral therapy in chronic hepatitis CE Grandini, F Cannoletta, A Scuteri, et al.
Oncology|January 1, 1989
Phase II trial of recombinant alpha-2b interferon in the treatment of metastatic skin melanomaM R Sertoli, M G Bernengo, A Ardizzoni, et al.
Vaccine|April 23, 2003
Red blood cell-mediated delivery of recombinant HIV-1 Tat protein in mice induces anti-Tat neutralizing antibodies and CTLS Dominici, M E Laguardia, G Serafini, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Revue Medicale Suisse|July 17, 2012
[Learning motivational interviewing to help patients change their health-related behaviors: medical students confirm it]C Fortini, J-B Daeppen
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics|September 1, 1982
[Problems of the therapy of neonatal convulsions]P Scarpa, R Chierici, C Fortini
Helvetica Paediatrica Acta|December 1, 1986
Neonatal periventricular leukomalacia: diagnosis and evolution evaluated by real-time ultrasoundL Tamisari, V Vigi, C Fortini, et al.
Brain & Development|January 1, 1983
Criteria for discontinuing neonatal seizure therapy: a long-term appraisalP Scarpa, R Chierici, L Tamisari, et al.
Revue Medicale Suisse|October 27, 2006
[Motivational interviewing: some theoretical aspects and some practical exercises]P Gache, C Fortini, A Meynard, et al.
Scandinavian Journal of Immunology|November 13, 2008
Inhibition of serine-peptidase activity enhances the generation of a survivin-derived HLA-A2-presented CTL epitope in colon-carcinoma cellsG Preta, D Marescotti, C Fortini, et al.
Human Genetics|September 1, 1993
Molecular analysis of G6PD variants in northern Italy: a study on the population from the Ferrara districtP Ninfali, L Baronciani, A Ruzzo, et al.
Annals of the New York Academy of Sciences|June 12, 2010
Immunological modifications during treatment with thymosin alpha1 plus antiviral therapy in chronic hepatitis CE Grandini, F Cannoletta, A Scuteri, et al.
Oncology|January 1, 1989
Phase II trial of recombinant alpha-2b interferon in the treatment of metastatic skin melanomaM R Sertoli, M G Bernengo, A Ardizzoni, et al.
Vaccine|April 23, 2003
Red blood cell-mediated delivery of recombinant HIV-1 Tat protein in mice induces anti-Tat neutralizing antibodies and CTLS Dominici, M E Laguardia, G Serafini, et al.
Pageof 2